Over the past 5 years, telehealth has grown from an emergency stopgap during the COVID-19 pandemic to a cornerstone of modern health care. Whether for routine check-ups, mental health counseling, or chronic disease management, telehealth has bridged the gap for patients who might otherwise struggle to access care — due to …

2024年11月22日 · The 2025 GOLD COPD report, titled “Global Strategy for Prevention, Diagnosis and Management of COPD: 2025 Report,” can now be downloaded from the GOLD website, along with a pocket guide to the report and the “2025 …

Chronic obstructive pulmonary disease (COPD) is a significant global health concern, ranking as the third-leading cause of mortality worldwide and affecting around 480 million people. 1,2 Its hallmark symptoms include persistent cough, breathlessness, and excessive mucus production, which not only impede daily activities but also contribute to …

For select patients with COPD, nebulized drugs might offer an alternative to a breath-actuated, hand-held inhaler. 5 Adherence to inhaled medication in patients with COPD is low, with the nonadherence rate ranging from 50% to 80%. 6 Among the causes of nonadherence is the inability to use an inhaler as directed. 6 Inhalers can be nearly impossible to use for patients who have a low inspiratory ...

2023年12月8日 · The 2024 GOLD Report, “Global Strategy for Prevention Diagnosis and Management of COPD,” not only includes guideline updates that reflect the latest research on chronic obstructive pulmonary disease (COPD); it also reflects some shifts in thinking about what’s important in COPD treatment, according to Claus Vogelmeier, MD, a lead report author and science committee chair for the Global ...

2025年1月8日 · Individuals with early-onset chronic obstructive pulmonary disease (COPD) and rapidly progressive pre-COPD frequently have a decades-long history of wheeze and an impaired lung function trajectory, according to study findings published in The Lancet Respiratory Medicine.. Researchers assessed whether individuals with an impaired long-term trajectory of forced expiratory volume in 1 second to ...

2023年1月20日 · The 2023 report from the Global Initiative for Chronic Obstructive Lung Disease (GOLD) — “Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease” (COPD) 1 — details “an expanded range of therapies for COPD that now can be considered to improve mortality,” according to Gerard J. Criner, MD, FACP, FACCP, an author of the 2023 GOLD ...

Over the past 5 years, telehealth has grown from an emergency stopgap during the COVID-19 pandemic to a cornerstone of modern health care. Whether for routine check-ups, mental health counseling, or chronic disease management, telehealth has bridged the gap for patients who might otherwise struggle to access care — due to …

2024年10月1日 · The Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance therapy for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.. The approval was supported by data from the randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS (ClinicalTrials.gov Identifier ...

2025年1月27日 · Researchers extracted overall and risk factor-associated trachea, bronchus, and lung cancer age-standardized mortality rates in the 10 most populated countries for 1990 to 2019 from the Global Burden of Disease database to examine trends.